Jump to section
To create a revolutionary, engaging, and accessible STEM learning experience that is globally scalable.
Some candidates hear
back within 2 weeks
-31% employee growth in 12 months
Accessing laboratories and professional workspaces is essential for practical experience in areas such as science and nursing, but this is generally only possible at universities. This is due to a lack of funding and necessity for such equipment in schools and colleges, yet the practical nature of laboratories shows potential to help illustrate abstract scientific concepts to young students.
Labster develops virtual laboratories that allow students to conduct experiments and visualize abstract scientific concepts through digital equipment, providing a practical experience in order to improve their learning experience. The virtual environments are aligned with STEM curriculums, paid for by educational institutes, and can be accessed through any computer without requiring additional software.
Virtual reality shows great potential for providing virtual working environments for a range of educational applications, but these usually require expensive VR setups such as headsets, high-spec computers, and controllers. Labster on the other hand has taken a bare-bones approach by providing its environments within a web browser, helping to provide an augmented learning experience to all students equally. In 2023 after a significant 2022 VC round, Labster made the news for the donation of its product to Ukrainian students for a second year running.
Freddie
Company Specialist at Welcome to the Jungle
Apr 2022
$47m
LATE VC
Feb 2021
$60m
SERIES C
This company has top investors
Received a Ph.D. in Synthetic Biology and Bioinformatics from The Technical University of Denmark in 2015. Experience as Founder and Board Member of Mailbird.
Mads Tvillinggaard Bonde
(Executive Chairman)Received Ph.D. in Synthetic Biology and Bioinformatics in 2015 at the Technical University of Denmark. Honorary Associate Professor at the Department of Drug Design and Pharmacology (ILF) at the University of Copenhagen.